Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Design Clinical Protocol (NAII, ULUR)

Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced the list of major milestone tasks that it plans to achieve before it begins its Phase IIB trial in pancreatic cancer. The company stated it will have a clinical protocol that will be designed in coordination with Contract Research Organization and its team of oncologists. This designed protocol can be […]

Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)

Providing updates on objectives, Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that it will form an IND team to design the IND and assess it before being officially filed with the regulatory authorities. He company’s IND Team will include a Project Manager, a Medical Officer, a Statistician, a Chemistry, Controls and Manufacturing Expert, a Pharmacologist, a Pharmakineticist, […]

Pharmacyte Biotech Inc (OTCMKTS:PMCB), Uluru Inc (OTCMKTS:ULUR) And Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Declines Over 5%

Pharmacyte Biotech Inc (OTCMKTS:PMCB) updated on the process of the compliance process completion of the Austrianova’s current Good Manufacturing Practices-compliant facility in Thailand. The encapsulation process of genetically modified human cells in the unique Cell-in-a-Box® capsules will be carried out in this facility. This are the same capsules that the company intends to use in […]

Can Pharmacyte Biotech Inc (OTCMKTS:PMCB) Move Up On The Chart?

In last trading session, the stock price of Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% to close the week at $0.0959. The decline came at a share volume of 1.06 million compared to monthly average share volume of 1.52 million. Pharmacyte stock has been stuck in a low trading session from last few trading sessions. Recently, […]